Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05142618 · ClinicalTrials.gov registry record · NA
Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair
A NA study of Ventral Hernia and Hernia, sponsored by Ohio State University.
- Active
- Registry status
- NA
- Development phase
- 138
- Enrollment target
- 1
- Study location
NCT05142618: Active NA study of Ventral Hernia and Hernia, sponsored by Ohio State University.
NCT05142618 is a NA study of Ventral Hernia and Hernia that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 138 participants, roughly in line with the 135-participant average among 18 other Ventral Hernia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05142618, a NA study of Ventral Hernia and Hernia, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the potential role of physical therapy in improving outcomes after ventral hernia repair.
Primary Outcome
From a standard chair, stand and sit back down five times in immediate succession as quickly as possible. The test is scored in seconds, where a shorter time represents greater mobility.
Conditions Studied
Interventions
- OTHER Supervised Physical Therapy
- OTHER Post-operative Precautions
Study Locations (1)
Ohio
- Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2022-04-19 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT05142618 still lists
NCT05142618 is an interventional study that assigns participants to a tested intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 135-participant average among 18 other Ventral Hernia trials with a reported enrollment target.
The record links to 6 conditions, with Ventral Hernia appearing as the primary indexed condition, and to 2 interventions - of which Supervised Physical Therapy is the first listed.
NCT05142618 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05142618 about?
NCT05142618 is a clinical study titled "Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair". This study aims to evaluate the potential role of physical therapy in improving outcomes after ventral hernia repair.
What is the current status of trial NCT05142618?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 138 participants. The study started on 2022-04-19. Estimated completion is 2025-12.
What conditions does trial NCT05142618 study?
This clinical trial studies the following conditions: Ventral Hernia, Hernia, Herniorrhaphy, Abdominal Wall, Postoperative Period.
What interventions are being tested in trial NCT05142618?
The interventions under investigation include: Supervised Physical Therapy (OTHER), Post-operative Precautions (OTHER).
Who is sponsoring clinical trial NCT05142618?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05142618 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05142618's enrollment target sits among peer trials
138 8th of 18 higher than 11 of 18 other Ventral Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventral Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)
ACTIVE NOT RECRUITING · NA
-
CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs
ACTIVE NOT RECRUITING · NA
-
Mesh Type in Ventral Hernia Repair
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI